Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing reevaluation of Zhuifeng Tougu capsules for rheumatoid arthritis
ChiCTR2000028806Phase 4Recruiting
- Sponsor
- Temporarily not sure
- Start
- Sep 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Zhuifeng Tougu capsules in rheumatoid arthritis (RA) (2 arms), sponsored by Temporarily not sure. Primary endpoint: Related symptoms and signs. Started Sep 2019; status: recruiting.
02
Drugs
Zhuifeng Tougu capsules
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2000028806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028806.